Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.
Class I - DangerousWhat Should You Do?
- Check if you have this product: All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Teva North America
- Reason for Recall:
- CGMP Deviations
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.
Product Codes/Lot Numbers:
All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1496-2016
Related Recalls
Class I - Dangerous
Failed Impurities/Degradation Specifications.
Class I - Dangerous
CGMP Deviations
Class I - Dangerous
CGMP Deviations